今天成都9路公交车的惨剧令人心痛。在中国，在这个官僚横行，伪善和虚与委蛇泛滥，口号和实际相分裂，人命如贱草，草根如蝼蚁的国度里面，老百姓真活得太不容易了。

大爷不和你玩了还不行嘛：删手们；被阉割了声带、良心的媒体从业者们；伟光正们；以及电子长城背后的喽罗们？

最新一篇日志，《他们，预测了汶川地震》的全文转载，被删。

大概某些强力机构的痛处被揭到了吧，现发链接：

http://www.my1510.cn/article.php?id=99b95667a9069ad8

http://www.my1510.cn/article.php?id=b50ce29d29d6f725

http://www.my1510.cn/article.php?id=11c0ab1c21c78533

http://www.my1510.cn/article.php?id=3a46a928e8583efb

http://www.my1510.cn/article.php?id=c8743e3d4b4d290d

你又来删除吧。

3G大幕已开，从网速、技术、与世界潮流契合度上讲，我最期待联通的WCDMA。

联通3G广告宣传片也已经陆续见诸媒体，对比之前中国电信的“天翼”以及去年中国移动的"3G"广告宣传片。联通广告的立意明显高深不少，以对比的手法突出3G与旧有技术本质的提升，令人耳目一新。

联通3G宣传片

闲情偶记：回不去的乡镇 被改造的时代命运

HY是距离成都几十公里的一个乡镇，今天，我来到这里。

其实和我HY一点关系都没有，它既不是我的故乡，也不是某个名胜所在，但鬼使神差，我来到此地。

昨晚成都平原才下过场雨，早上的空气清冷，像冬天。上午太阳出来，气温又像回到春天，让人昏昏欲睡。

HY临河，我也没去打听河的名称，两边的古旧店铺，一条泥泞破烂窄窄的街道像一根血管串起这个镇子。人很多，都是来赶场的人，很热闹，也很生活。

远处有大山轮廓，只是在阳光慢慢蒸腾的白色雾气中显得并不清晰。

一切都很破旧，地震之后，这个平原的各处地方便开始大兴建设，道路扩张，房屋推倒重建，到处都是泥泞，到处都是工程机械的轰鸣，到处都是被改造的命运。

人安然的接受这一切，接受堵车，接受泥泞，接受市井轰鸣，接受浮光与灰尘的弥漫。

我在那座破烂的桥上，看见一位正在打电话的短裤薄衫的小姑娘，很是惊艳，来往的男子无不多看上她几眼，我不知道她从哪里来，但看她打电话的从容，似乎就是本地人。当然，我也多看了她几眼，然后走了过去。中午吃饭的时，居然在小饭馆看到她，匆匆吃过一碗面，就走近对面的车站，然后就消失了。

我也匆匆离开了HY，这个普普通通的乡镇，好像内心也不再又再回去的愿望，因为它的破烂，泥泞还有到处被挖开的街道，推倒的房屋以及和自己的毫无关系。

你还记得你记事起的家么？可能从真正意义上，那才是故乡。不过，它可能已经消失，是的，我的那个家已经消失了，一座高土上，可以俯视周围的学校确实已经消失，不过，我记得它灰色的砖墙，红木的大门，夜晚的旱烟的香气，如此等等，非常的清晰。

只是，它们都已经不再。

我们都在奔向一个我们以为的好地方，一个我们认为比此地更好的地方，但我们的魂却留在了某处，我们可以选择逃离，我们的肉体可以在这个尘世漂流，但我们灵魂可能再也回不去。

未来是不可知的。现在是变化的。过往，是已经消失了的。我们暗自叹息的，不是具体过往内容的本身，而是消逝的过程。

别处可能永远是好的，只不过，等你抵达，你又会失望了。so,好与不好，只是相对和有时间限制的。

最好的时间，可能就是在从此地到彼地的过程中。

Chinese Government and Bill & Melinda Gates Foundation Announce Partnership to Fight Tuberculosis

At a global meeting of health ministers today, Bill Gates joined Chinese Minister of Health Chen Zhu to announce an innovative partnership to help fight a serious tuberculosis epidemic in China. The initiative will be led by the Chinese Ministry of Health and is supported by a grant of US$33 million over five years from the Bill & Melinda Gates Foundation.

The goal of the partnership is to improve detection and treatment of the estimated 1.5 million TB cases that occur each year in China, drawing on the latest innovations in TB control. Funding from the Gates Foundation will help China introduce new TB diagnostic tests, drug regimens, patient monitoring strategies, and health delivery approaches that could significantly improve the effectiveness of TB diagnosis and treatment across the country.

"This partnership with China comes at a critical time in the world’s response to tuberculosis," said Mr. Gates, co-chair of the Bill & Melinda Gates Foundation. "The rise of drug-resistant TB worldwide has created a new urgency to combat the disease, while scientific innovation is leading to new technologies that will help us succeed. China is taking the threat of TB very seriously, and we’re excited to support its efforts."

"This tuberculosis prevention and control program is a continuation of the successful cooperation between the Chinese Ministry of Health and the Gates Foundation that began on the issue of HIV/AIDS," said Minister Chen. "It aims to establish an effective TB prevention model through the exploration of new diagnostic tools and methods. This will not only benefit TB prevention and control efforts both in China and throughout the world, but it also sets an excellent example of the partnership between government and private sectors that is widely promoted by the international community, and we hope it will accelerate the progress of reaching the United Nations Millennium Development Goals."

Mr. Gates is in Beijing for a meeting with health ministers and senior officials from 27 countries affected by the rise of multi-drug resistant (MDR) TB and to sign a Memorandum of Understanding on this new partnership with the Chinese Ministry of Health. MDR TB is a form of the disease that is resistant to the two best TB drugs being used today and is especially difficult and costly to treat. According to the World Health Organization (WHO), China is one of the countries with the most serious MDR-TB epidemic.

"TB is an increasing threat because of gaps in the way the disease is diagnosed and treated," Mr. Gates said. "This partnership will help cut off drug resistance at its source by applying innovative approaches to strengthen basic TB control."

Following the completion of the first two-and-a-half years of this partnership, China will determine how to progressively expand the innovations that have been proven to be effective into 20 cities, diagnosing and treating 50,000 TB patients each year. This partnership will not only accelerate progress in the national TB control program; it will also provide evidence that can benefit other countries facing similar challenges in TB control.

Introduction to the New TB Partnership

Preparation for this new partnership began in 2007 and involved several rounds of discussions between the Chinese Ministry of Health and the Gates Foundation. The goal of the project is to improve the quality of TB control by using innovative tools and delivery methods. The project will bring together innovations that are effective in preventing, controlling and managing TB, thereby facilitating progress in the national TB control plan. The new technologies and innovative delivery methods to be piloted include:

    - New diagnostic tests that can dramatically improve detection of TB
    - Drug resistance tests that can identify MDR-TB in a matter of hours, as
      opposed to the six or more weeks that a standard test currently
      requires
    - New strategies to help TB patients take their medicines regularly for
      the entire 6-8 months of treatment, such as cell phone text messaging
      and medicine kits with built-in reminder alarms
    - Fixed-dose drug combinations that reduce the number of pills a patient
      has to take each day by 70%
    - A new model of collaboration between hospitals and the public health
      system to provide high-quality and affordable TB diagnosis and
      treatment
    - New incentives and approaches for health care workers to provide
      effective follow-up of TB patients during treatment
    - New approaches to ensure high-quality fixed-dose combination and second
      line TB drugs are produced

The foundation’s grant totals US$33 million and will be implemented in 6 provinces. The project will last for 5 years (2009-2014). During the first two-and-a-half years, innovative tools and delivery approaches will be pilot-tested to determine their effectiveness and feasibility. During the last two-and-a-half years, the most effective innovations will be further scaled up and evaluated. Beyond the five-year partnership, it is hoped that this large-scale demonstration will lead to national scale-up of these innovations across China.